| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.925.246 | 7.286.442 | 7.663.827 | 8.965.659 | 11.507.794 | 13.486.188 | 16.394.124 | 16.009.769 | 15.497.526 | 19.558.076 |
| Total Income - EUR | 6.384.579 | 7.886.255 | 7.732.642 | 9.040.196 | 11.550.671 | 13.562.001 | 16.537.024 | 16.215.141 | 15.710.773 | 19.697.793 |
| Total Expenses - EUR | 5.771.330 | 6.845.779 | 7.312.475 | 8.309.261 | 10.511.873 | 12.258.823 | 14.861.853 | 14.600.612 | 14.597.860 | 18.494.956 |
| Gross Profit/Loss - EUR | 613.249 | 1.040.476 | 420.167 | 730.935 | 1.038.798 | 1.303.177 | 1.675.172 | 1.614.529 | 1.112.914 | 1.202.837 |
| Net Profit/Loss - EUR | 496.124 | 844.148 | 326.324 | 601.318 | 856.317 | 1.060.615 | 1.398.863 | 1.415.304 | 911.569 | 1.009.622 |
| Employees | 26 | 30 | 35 | 37 | 39 | 42 | 40 | 39 | 38 | 45 |
Check the financial reports for the company - Queisser Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 49.650 | 43.019 | 36.097 | 51.391 | 59.048 | 90.775 | 86.722 | 107.565 | 192.592 | 224.931 |
| Current Assets | 4.831.268 | 4.943.295 | 5.233.537 | 5.651.454 | 7.139.359 | 8.530.683 | 10.648.131 | 11.128.895 | 11.848.994 | 13.805.100 |
| Inventories | 645.856 | 496.277 | 860.002 | 872.825 | 2.116.236 | 2.140.522 | 2.328.241 | 2.414.617 | 2.302.189 | 3.107.938 |
| Receivables | 3.088.126 | 3.656.630 | 3.639.765 | 4.305.835 | 4.247.778 | 5.996.228 | 7.793.742 | 7.091.174 | 7.178.430 | 8.417.107 |
| Cash | 1.097.286 | 790.388 | 733.770 | 472.795 | 775.345 | 393.934 | 526.147 | 1.623.105 | 2.368.374 | 2.280.055 |
| Shareholders Funds | 1.257.501 | 1.988.619 | 2.681.782 | 3.018.993 | 3.606.113 | 4.335.810 | 5.335.296 | 6.553.222 | 7.222.540 | 7.890.246 |
| Social Capital | 299.667 | 296.611 | 692.082 | 679.381 | 666.224 | 653.594 | 639.100 | 641.083 | 639.139 | 635.567 |
| Debts | 3.624.391 | 2.937.424 | 2.580.617 | 2.614.091 | 3.446.325 | 3.942.551 | 4.771.918 | 4.285.506 | 4.321.687 | 5.783.766 |
| Income in Advance | 1.559 | 4.482 | 6.594 | 4.201 | 3.203 | 7.376 | 7.481 | 8.387 | 6.632 | 6.354 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4638 - 4638" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Queisser Pharma Srl